Publications: Prof Nicholas Croft
Harvey PR, McNulty D, Coupland B, Kemos P, Croft NM, Trudgill NJ
(
2024
)
.
The Risk of Venous Thromboembolism in Children With Inflammatory Bowel Disease
.
Inflammatory Bowel Diseases
Noble A, Adams A, Nowak J, Cheng G, Nayak K, Quinn A, Kristiansen M, Kalla R et al.
(
2024
)
.
The Circulating Methylome in Childhood-Onset Inflammatory Bowel Disease
.
Journal of Crohn's and Colitis
Heredia M, Charrout M, Klomberg RCW, Aardoom MA, Jongsma MME, Kemos P, Haaften DHH-V, Tuk B et al.
(
2024
)
.
Combined plasma protein and Tmem profiling discern IBD-patient-immunotypes related to intestinal disease and treatment outcomes Short title: Defining immunotypes in CD and UC
.
Mucosal Immunology
Klomberg RCW, Croft NM, de Ridder L
(
2024
)
.
Rare and severe adverse events in children with inflammatory bowel disease - Authors' reply
.
The Lancet Child & Adolescent Health
vol.
8
,
(
9
)
e9
-
e10
.
Hodges P, Adeniyi O, Devani S, Nwoko C, Owoseni O, Boateng KGA, Ocanit A, Muhofa A et al.
(
2024
)
.
Emerging patterns of inflammatory bowel disease in sub-Saharan Africa: 175 cases from an IBD network
.
Journal of Crohn's and Colitisjjae126
-
jjae126
.
Pujol-Muncunill G, Navas-López VM, Ledder O, Cohen S, Lekar M, Turner D, Kolho K-L, Levine A et al.
(
2024
)
.
STEP-CD study: ustekinumab use in paediatric Crohn’s disease—a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN
.
European Journal of Pediatrics
vol.
183
,
(
8
)
3253
-
3262
.
Klomberg RCW, Hellendoorn AE, Kemos P, Rizopoulos D, Ruemmele FM, Croft NM, de Ridder L, collaborators P-SSR et al.
(
2024
)
.
Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry
.
The Lancet Child & Adolescent Health
vol.
8
,
(
6
)
422
-
432
.
Chanchlani N, Lin S, Bewshea C, Hamilton B, Thomas A, Smith R, Roberts C, Bishara M et al.
(
2024
)
.
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
.
The Lancet Gastroenterology & Hepatology
vol.
9
,
(
6
)
521
-
538
.
Higham JP, Bhebhe CN, Gupta RA, Tranter MM, Barakat FM, Dogra H, Bab N, Wozniak E et al.
(
2024
)
.
Transcriptomic profiling reveals a pronociceptive role for angiotensin II in inflammatory bowel disease
.
Pain
vol.
165
,
(
7
)
1592
-
1604
.
Croft NM, Hodges P, Kelly P, Alatise O, Boateng KGA, Katsidzira L, Duduyemi B, Adeniyi F et al.
(
2024
)
.
ECCO Global Grant Genetic risk factors for IBD in its emergent phase in sub-Saharan Africa
.
vol.
18
,
is.
Supplement_1
,
pp.
i2259
-
i2259
.
Oxford University Press (OUP)
Kherati R, Bansal A, Oleksiewicz J, Kadir A, Burgess N, Barr S, Naik S, Croft NM et al.
(
2024
)
.
The impact of age, disease severity, and BMI on bone health and growth in children and young people with Crohn's disease
.
JPGN Reports
vol.
5
,
(
1
)
17
-
28
.
Klomberg RCW, van der Wal HC, Aardoom MA, Kemos P, Rizopoulos D, Ruemmele FM, Charrout M, Escher HC et al.
(
2023
)
.
Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn’s Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort Study
.
Journal of Crohn's and Colitis
vol.
18
,
(
5
)
738
-
750
.
Croft NM, Korczowski B, Kierkuś J, Caballero B, Thakur MK
(
2023
)
.
Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind study
.
EClinicalMedicine
vol.
65
,
Adeniyi OF, Lesi OA, Odeghe EA, Oyeleke G, Croft N
(
2023
)
.
Gastrointestinal Bleeding in Children: The Role of Endoscopy and the Sheffield Scoring System in a Resource‐Limited Setting
.
JPGN Reports
vol.
4
,
(
4
)
e369
-
e369
.
Bai BYH, Reppell M, Smaoui N, Waring JF, Pivorunas V, Guay H, Lin S, Chanchlani N et al.
(
2023
)
.
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients
.
Journal of Crohn's and Colitis
vol.
18
,
(
3
)
431
-
445
.
Kherati R, Robinson P, Bansal A, Oleksiewicz J, Croft N, Kadir A, Naik S, Burgess N et al.
(
2023
)
.
OC25 Aiming for growth targets and optimised bone health in children with crohn’s disease
.
Conference:
Top of Forma17.2
-
a1a18
.
Atia O, Klomberg RCW, de Ridder L, Kemos P, Ruemmele FM, Kang B, Choi S, Choe B et al.
(
2023
)
.
Validation of predictive models for disease outcomes in paediatric ulcerative colitis: A multicentre prospective inception cohort
.
Alimentary Pharmacology & Therapeutics
vol.
58
,
(
2
)
182
-
190
.
Marcovitch L, Focht G, Carmon N, Tersigni C, Ledder O, Lev-Tzion R, Church PC, Hyams JS et al.
(
2022
)
.
Development and Validation of the TUMMY-UC: A Patient-Reported Outcome for Pediatric Ulcerative Colitis
.
Gastroenterology
vol.
164
,
(
4
)
610
-
618.e4
.
Cheng K, Mahler F, Lutsar I, Escalera BN, Breitenstein S, Vassal G, Claverol J, Palacio NN et al.
(
2022
)
.
Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children
.
Clinical and Translational Science
vol.
16
,
(
3
)
478
-
488
.
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R et al.
(
2022
)
.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
.
The Lancet Gastroenterology & Hepatology
vol.
8
,
(
2
)
145
-
156
.
Croft NM, de Ridder L, Griffiths AM, Hyams JS, Ruemmele FM, Turner D, Cheng K, Lutsar I et al.
(
2022
)
.
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents
.
Journal of Crohn's and Colitis
vol.
17
,
(
2
)
249
-
258
.
Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM et al.
(
2022
)
.
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease
.
Nature Communications
vol.
13
,
(
1
)
3576
-
3576
.
Torrente F, Meade S, Benchimol EI, de Ridder L, Croft NM, Kammermeier J, Mack DR, Klomberg RCW et al.
(
2022
)
.
Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel
.
Journal of Crohn's and Colitis
vol.
16
,
(
10
)
1609
-
1616
.
Stodtmann S, Chen M-J, Siovitz L, Bereswill M, Lazar A, Croft N, Kierkus J, Faubion WA et al.
(
2022
)
.
Bridging Fixed Dose to Body Weight-based Regimen of Adalimumab in Paediatric Ulcerative Colitis Using a Pharmacometric Modelling Approach: Case Study with the Phase 3 ENVISION I Trial
.
Journal of Crohn's and Colitis
vol.
16
,
(
10
)
1551
-
1561
.
Klomberg RCW, Aardoom MA, Kemos P, Rizopoulos D, Ruemmele FM, Croft NM, de Ridder L, Neyt M et al.
(
2022
)
.
High Impact of Pediatric Inflammatory Bowel Disease on Caregivers’ Work Productivity and Daily Activities: An International Prospective Study
.
The Journal of Pediatrics
vol.
246
,
95
-
102.e4
.
Hyams JS, Turner D, Cohen SA, Szakos E, Kowalska-Duplaga K, Ruemmele F, Croft NM, Korczowski B et al.
(
2022
)
.
Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study
.
Journal of Crohn's and Colitis
vol.
16
,
(
8
)
1243
-
1254
.
Mulberg AE, Conklin LS, Croft NM, Group I-AFCPEW, Parikh A, Bousvaros A, DeZoeten E, Dubinsky M et al.
(
2022
)
.
Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug Development
.
Gastroenterology
vol.
163
,
(
1
)
77
-
83
.
Gasparetto M, Burgess N, Naik S, Studart D, Kadir A, Croft N, Sanderson I, Deb P
(
2022
)
.
Advantages of Proactive Therapeutic Drug Monitoring in a Prospective Cohort of Children With Inflammatory Bowel Disease Treated With Anti-TNF
.
J Pediatr Gastroenterol Nutr
Berger TD, Lee HM, Padmanaban LR, Wine E, Yerushalmy-Feler A, Hojsak I, Kazeka D, Serban DE et al.
(
2021
)
.
Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn's Disease
.
J Pediatr Gastroenterol Nutr
vol.
74
,
258
-
266
.
Aardoom MA, Klomberg RCW, Kemos P, Ruemmele FM, van Ommen H, de Ridder L, Croft NM
(
2021
)
.
The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry
.
J Crohns Colitis
Walsh CM, Lightdale JR, Mack DR, Amil-Dias J, Bontems P, Brill H, Croft NM, Fishman DS et al.
(
2021
)
.
Overview of the Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Quality Standards and Indicators for Pediatric Endoscopy: A Joint NASPGHAN/ESPGHAN Guideline
.
J Pediatr Gastroenterol Nutr
Lightdale JR, Walsh CM, Fishman DS, Furlano RI, Mamula P, Gillett PM, Narula P, Hojsak I et al.
(
2021
)
.
Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Pediatric Endoscopy Reporting Elements: A Joint NASPGHAN/ESPGHAN Guideline
.
J Pediatr Gastroenterol Nutr
Lightdale JR, Walsh CM, Oliva S, Jacobson K, Huynh HQ, Homan M, Hojsak I, Gillett PM et al.
(
2021
)
.
Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Quality Standards and Indicators for Pediatric Endoscopic Procedures: A Joint NASPGHAN/ESPGHAN Guideline
.
J Pediatr Gastroenterol Nutr
Walsh CM, Lightdale JR, Leibowitz IH, Lerner DG, Liu QY, Mack DR, Mamula P, Narula P et al.
(
2021
)
.
Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Quality Standards and Indicators for Pediatric Endoscopists and Endoscopists in Training: A Joint NASPGHAN/ESPGHAN Guideline
.
J Pediatr Gastroenterol Nutr
Lightdale JR, Walsh CM, Narula P, Utterson EC, Tavares M, Rosh JR, Riley MR, Oliva S et al.
(
2021
)
.
Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Quality Standards and Indicators for Pediatric Endoscopy Facilities: A Joint NASPGHAN/ESPGHAN Guideline
.
J Pediatr Gastroenterol Nutr
Croft NM, Faubion WA, Kugathasan S, Kierkus J, Ruemmele FM, Shimizu T, Mostafa NM, Venetucci M et al.
(
2021
)
.
Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study
.
The Lancet Gastroenterology & Hepatology
vol.
6
,
(
8
)
616
-
627
.
Gasparetto M, Burgess N, Studart D, Naik S, Kadir A, Croft N, Sanderson I, Deb P
(
2021
)
.
P07 A single-centre prospective observational study comparing proactive with reactive therapeutic drug monitoring (TDM) in two cohorts of children with inflammatory bowel disease (IBD)
.
Frontline Gastroenterology
.
Conference:
British Society of Paediatric Gastroenterology, Hepatology and Nutrition
vol.
12
,
a13
-
a14
.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J et al.
(
2021
)
.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
.
Gut
vol.
70
,
(
5
)
865
-
875
.
Shea T, Athanasakos E, Cleeve S, Croft N, Gibbs D
(
2021
)
.
Pediatric Medical Traumatic Stress
.
The Journal of Child Life Psychosocial Theory and Practice
vol.
2
,
(
1
)
Shea T, Athanasakos E, Cleeve S, Croft N, Gibbs D
(
2021
)
.
Pediatric medical traumatic stress: A scoping review
.
The Journal of Child Life: Psychosocial Theory and Practice
vol.
2
,
(
1
)
44
-
54
.
McGregor CG, Adams A, Sadler R, Arancibia-Cárcamo CV, Palmer R, Ambrose T, Brain O, Walsh A et al.
(
2021
)
.
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic
.
Gut
vol.
70
,
(
12
)
2398
-
2400
.
Neyt M, Christiaens A, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D et al.
(
2021
)
.
Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment
.
JMIR Formative Research
vol.
5
,
(
1
)
Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM et al.
(
2020
)
.
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease
.
Nature Communications
vol.
11
,
(
1
)
Hansen R, Meade S, Beattie RM, Auth MK, Croft N, Davies P, Devadason D, Doherty C et al.
(
2020
)
.
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel
.
Gut
vol.
70
,
(
6
)
1044
-
1052
.
Aardoom MA, Kemos P, Tindemans I, Aloi M, Koletzko S, Levine A, Turner D, Veereman G et al.
(
2020
)
.
International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study
.
BMJ open
vol.
10
,
(
7
)
e035538
-
e035538
.
Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G et al.
(
2020
)
.
Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course
.
BMJ open
vol.
10
,
(
7
)
e034892
-
e034892
.
Tan ZV, Kosana K, Savarino J, Croft N, Naik S, Kaplan J, Giles E
(
2020
)
.
Histology at diagnostic gastroscopy predicts outcome after intestinal resection in pediatric Crohn's disease
.
Journal of Gastroenterology and Hepatology
vol.
35
,
(
12
)
2074
-
2079
.
Aardoom M, Kemos P, Ruemmele F, van Ommen CH, Croft NM, de Ridder L
(
2020
)
.
Mo1900 THE INCIDENCE AND CHARACTERISTICS OF VENOUS THROMBOEMBOLISMS IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE
.
Gastroenterology
.
vol.
158
,
s
-
970
.
Costes L, Tindemans I, Joosse ME, Aardoom MA, Jongsma MME, Raatgeep RHC, van Haaften DH, Alexander KL et al.
(
2020
)
.
DOP09 IgG responses to multiple bacterial flagellins identify a subgroup of paediatric therapy-naive Crohn’s disease patients with increased microbiota-specific T-cell reactivity
.
Journal of Crohn's and Colitis
.
vol.
14
,
s046
-
s046
.
Aardoom M, Kemos P, Ruemmele FM, van Ommen CH, Croft NM, de Ridder L
(
2020
)
.
P116 The occurrence of venous thromboembolisms in paediatric-onset IBD
.
Journal of Crohn's and Colitis
.
vol.
14
,
s194
-
s194
.
Costes L, Tindemans I, Joosse ME, Aardoom MA, Jongsma MME, Raatgeep RHC, van Haaften DH, Alexander KL et al.
(
2020
)
.
IgG responses to multiple bacterial flagellins identify a subgroup of paediatric therapynaive Crohn's disease patients with increased microbiota-specific T-cell reactivity
.
JOURNAL OF CROHNS & COLITIS
.
vol.
14
,
S046
-
S046
.
Aardoom M, Kemos P, Ruemmele F, van Ommen CHH, Croft NM, de Ridder L
(
2020
)
.
THE INCIDENCE AND CHARACTERISTICS OF VENOUS THROMBOEMBOLISMS IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE
.
Aardoom M, Kemos P, Ruemmele FM, van Ommen CH, Croft NM, de Ridder L
(
2020
)
.
The occurrence of venous thromboembolisms in paediatric-onset IBD
.
JOURNAL OF CROHNS & COLITIS
.
vol.
14
,
S194
-
S194
.
Sazonovs A, Kennedy NA, Moutsianas L, Heap GA, Rice DL, Reppell M, Bewshea CM, Chanchlani N et al.
(
2019
)
.
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease
.
Gastroenterology
vol.
158
,
(
1
)
189
-
199
.
De Jesus H, Ooms A, Norton C, Dibley L, Croft N
(
2019
)
.
Development of self-management in pediatric inflammatory bowel disease: A qualitative exploration
.
Journal of Nursing Education and Practice
vol.
9
,
(
11
)
75
-
75
.
Krauthammer A, Tzivinikos C, Assa A, Miele E, Strisciuglio C, Urlep D, Serban ED, Singh A et al.
(
2019
)
.
Long-term Outcomes of Paediatric Patients Admitted with Acute Severe Colitis - A Multicenter Study from the Paediatric IBD Porto Group of ESPGHAN
.
J Crohns Colitis
Rao A, Kemos P, Kamperidis N, Naik S, Croft NM, Sanderson I
(
2019
)
.
CHILDREN WITH CROHN'S DISEASE WHO RESPOND TO AN ENTERAL DIET ARE TWICE AS LIKELY TO REMAIN IN CLINICAL REMISSION OVER 5 YEARS
.
GASTROENTEROLOGY
.
Conference:
Digestive Diseases Week (American Gastroenterological Association)
vol.
156
,
S615
-
S616
.
Vavilikolanu R, Sanderson I, Naik S, Croft NM, Kemos P
(
2019
)
.
G118(P) The risk of nephrotoxicity from 5-ASA in children with ulcerative colitis (UC) is not dose related
.
Archives of Disease in Childhood
.
Conference:
Royal College of Paediatrics and Child Health
vol.
104
,
a48
-
a48
.
Rao A, Kemos P, Kamperidis N, Naik S, Croft NM, Sanderson I
(
2019
)
.
Su1797 – Children with Crohn’s Disease Who Respond to an Enteral Diet are Twice As Likely to Remain in Clinical Remission Over 5 Years
.
Gastroenterology
.
vol.
156
,
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R et al.
(
2019
)
.
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
.
The Lancet Gastroenterology & Hepatology
vol.
4
,
(
5
)
341
-
353
.
Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC et al.
(
2019
)
.
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease
.
JAMA
vol.
321
,
(
8
)
773
-
785
.
Aardoom MA, Kemos P, Ruemmele F, Tindemans I, Samsom JN, Croft N, de Ridder L
(
2019
)
.
P165 A global prospective observational study in children and adolescents with paediatric-onset IBD: the PIBD-SETQuality inception cohort
.
Journal of Crohn's and Colitis
.
vol.
13
,
s171
-
s172
.
Aardoom MA, Kemos P, Ruemmele F, Croft N, de Ridder L
(
2019
)
.
P596 An ongoing safety registry to identify rare and severe complications in children with paediatric-onset IBD
.
Journal of Crohn's and Colitis
.
vol.
13
,
s413
-
s413
.
Turner D, Ruemmele FM, Orlanski‐Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M et al.
(
2018
)
.
Management of Paediatric Ulcerative Colitis, Part 1
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
67
,
(
2
)
257
-
291
.
Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M et al.
(
2018
)
.
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition
.
J Pediatr Gastroenterol Nutr
vol.
67
,
(
2
)
257
-
291
.
Turner D, Ruemmele FM, Orlanski‐Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M et al.
(
2018
)
.
Management of Paediatric Ulcerative Colitis, Part 2
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
67
,
(
2
)
292
-
310
.
Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M et al.
(
2018
)
.
Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition
.
J Pediatr Gastroenterol Nutr
vol.
67
,
(
2
)
292
-
310
.
Auth MK-K, Bunn SK, Protheroe AL, Williams LJ, Fell JM, Muhammed R, Croft NM, Beattie RM et al.
(
2018
)
.
Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom
.
Inflamm Bowel Dis
vol.
24(7)
,
(
Jun 8
)
1520
-
1530
.
Crane MB, Grant A, Hyams J, Croft N, Mack DR, Hussey S, Sylvester F, Huynh HQ et al.
(
2018
)
.
A132 DEVELOPMENT OF THE TUMMY-CD, A SYMPTOMS-BASED DISEASE ACTIVITY PATIENT REPORTED OUTCOME (PRO) FOR PEDIATRIC CROHN’S DISEASE
.
Journal of the Canadian Association of Gastroenterology
.
vol.
1
,
197
-
198
.
Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM et al.
(
2018
)
.
Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response
.
J Pediatr Gastroenterol Nutr
vol.
66
,
(
2
)
274
-
280
.
Marcovitz L, Nissan A, Horesh A, Mack D, Hussey S, Otley A, Croft N, Kappelman M et al.
(
2018
)
.
P133 Cognitive debriefing interviews (phase 2B) towards developing a Patient Reported Outcome measure for Paediatric ulcerative colitis- the TUMMY-UC
.
Journal of Crohn's and Colitis
.
vol.
12
,
s161
-
s162
.
Aardoom M, Kemos P, Ruemmele F, Croft N, de Ridder L, consortium and PIBDnet OBOTPS
(
2018
)
.
P584 Rare and severe complications in children with paediatric-onset IBD; the international PIBD SETQuality Safety Registry by PIBDnet
.
Journal of Crohn's and Colitis
.
vol.
12
,
s403
-
s404
.
Kemos P, Aardoom M, Ruemmele F, de Ridder L, Croft N, consortium and PIBDnet OBOTPS
(
2018
)
.
P785 Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complications
.
Journal of Crohn's and Colitis
.
vol.
12
,
s508
-
s508
.
Marcovitz L, Nissan A, Horesh A, Mack D, Hussey S, Otley A, Croft N, Kappelman M et al.
(
2018
)
.
Cognitive debriefing interviews (phase 2B) towards developing a Patient Reported Outcome measure for Paediatric ulcerative colitis- the TUMMY-UC
.
JOURNAL OF CROHNS & COLITIS
.
vol.
12
,
S161
-
S162
.
Kemos P, Aardoom M, Ruemmele F, de Ridder L, Croft N
(
2018
)
.
Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complications
.
JOURNAL OF CROHNS & COLITIS
.
vol.
12
,
S508
-
S508
.
Aardoom M, Kemos P, Ruemmele F, Croft N, de Ridder L
(
2018
)
.
Rare and severe complications in children with paediatric-onset IBD; the international PIBD SETQuality Safety Registry by PIBDnet
.
JOURNAL OF CROHNS & COLITIS
.
vol.
12
,
S403
-
S404
.
Wang S, Younus O, Rawat D, Naik S, Giles E, Meadows N, Croft NM
(
2017
)
.
Clinical Presentation and Outcomes of Diagnostic Endoscopy in Newly Presenting Children with Gastrointestinal Symptoms
.
J Pediatr Gastroenterol Nutr
Schwerd T, Bryant RV, Pandey S, Capitani M, Meran L, Cazier J-B, Jung J, Mondal K et al.
(
2017
)
.
NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease
.
Mucosal Immunology
vol.
11
,
(
2
)
562
-
574
.
Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MK, Elawad M, Fell JM, Beattie RM et al.
(
2017
)
.
Real-Life Anti-Tumour Necrosis Factor Experience in > 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients
.
J Pediatr Gastroenterol Nutr
CROFT NM, GILES E
(
2017
)
.
Autoimmune Gastropathy
.
Esophageal and Gastric Disorders in Infancy and Childhood
,
Springer
Marcovitch L, Nissan A, Mack D, Otley A, Hussey S, Mclean B, Lewis M, Croft N et al.
(
2017
)
.
Item Generation and Reduction Toward Developing a Patient-reported Outcome for Pediatric Ulcerative Colitis (TUMMY-UC)
.
J Pediatr Gastroenterol Nutr
vol.
64
,
(
3
)
373
-
377
.
Tranter M, Barakat F, Dogra H, Lindsay J, Croft N, Bulmer D
(
2017
)
.
MMP-12, a novel mediator of nociception in Crohn's disease
.
JOURNAL OF CROHNS & COLITIS
.
Conference:
European Crohn's and Colitis (ECCO) Congress 2017
vol.
11
,
S120
-
S120
.
Tranter M, Barakat F, Dogra H, Lindsay J, Croft N, Bulmer D
(
2017
)
.
P086 MMP-12, a novel mediator of nociception in Crohn's disease
.
J Crohns Colitis
.
vol.
11
,
S120
-
S120
.
Wang S, Younus O, Naik S, Rawat D, Meadows N, Giles E, Croft N
(
2016
)
.
G31 Diagnostic endoscopy in newly presenting children with Gastrointestinal Symptoms: Indications and outcomes
.
Archives of Disease in Childhood
.
vol.
101
,
Afzal N, Lloyd C, Narula P, Gupte G, Croft N, Baker A
(
2016
)
.
G32 Variation in upper GI bleeding service provision for children in the United Kingdom – a nation-wide survey by British Society of Paediatric Gastroenterology Hepatology and Nutrition (BSPGHAN)
.
Archives of Disease in Childhood
.
vol.
101
,
Croft NM, Faubion W, Tierens D, Dewulf J, Bwirire D, Stefani-Hunyady D, Cataldi F
(
2016
)
.
Su1925 Feasibility of a Placebo-Controlled, Randomized Mesalamine Withdrawal Study in Children and Adolescents With Ulcerative Colitis
.
Gastroenterology
.
vol.
150
,
s590
-
s591
.
Croft N, Faubion W, Tierens D, Dewulf J, Bwirire D, Stefani-Hunyady D, Cataldi F
(
2016
)
.
Indication-specific feasibility assessment of a placebo-controlled randomised mesalazine withdrawal study for paediatric patients with ulcerative colitis
.
JOURNAL OF CROHNS & COLITIS
.
vol.
10
,
S336
-
S337
.
Mt‐Isa S, Tomlin S, Sutcliffe A, Underwood M, Williamson P, Croft NM, Ashby D
(
2015
)
.
Prokinetics Prescribing in Paediatrics
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
60
,
(
4
)
508
-
514
.
Tranter M, Barakat F, Bulmer D, Croft N
(
2015
)
.
How do IBD supernatants activate visceral sensory afferents?
.
NEUROGASTROENTEROLOGY AND MOTILITY
.
vol.
27
,
104
-
104
.
Johal A, Abed Al Jawad F, Marcenes W, Croft N
(
2013
)
.
Does orthodontic treatment harm children's diets?
.
J Dent
vol.
41
,
(
11
)
949
-
954
.
Goodhand JR, Kamperidis N, Sirwan B, Macken L, Tshuma N, Koodun Y, Chowdhury FA, Croft NM et al.
(
2013
)
.
Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease
.
Aliment Pharmacol Ther
vol.
38
,
(
9
)
1097
-
1108
.
Russell RK, Protheroe A, Roughton M, Croft NM, Murphy MS, Spray C, Rodrigues AF, Wilson DC et al.
(
2013
)
.
Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom
.
Inflamm Bowel Dis
vol.
19
,
(
7
)
1434
-
1440
.
Goodhand J, Kamperidis N, Sirwan B, Macken L, Tshuma N, Koodun Y, Chowdhury F, Croft N et al.
(
2013
)
.
P335 Thiopurine nonadherence is more common in adolescents than adults with IBD, is associated with psychological distress and impacts on the management and prognosis
.
Journal of Crohn's and Colitis
.
vol.
7
,
s144
-
s144
.
Giles E, Hanci O, McLean A, Power N, Cole A, Croft NM, McDonald K, Chippington S et al.
(
2012
)
.
Optimal assessment of paediatric IBD with MRI and barium follow-through
.
J Pediatr Gastroenterol Nutr
vol.
54
,
(
6
)
758
-
762
.
Russell RK, Protheroe A, Roughton M, Croft N, Murphy MS, Spray C, Rodrigues A, Wilson DC et al.
(
2012
)
.
OC-050 Inpatient paediatric UC care in the UK in 2011 is characterised by increasing rates of rescue therapy and stool cultures but low use of pucai scores
.
Gut
.
vol.
61
,
Kamperidis N, Goodhand JR, Chowdhury FA, Koodun Y, Direzke NC, Naik S, Sanderson IR, Croft NM et al.
(
2012
)
.
Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel disease
.
J Pediatr Gastroenterol Nutr
vol.
54
,
(
5
)
685
-
689
.
Goodhand JR, Kamperidis N, Joshi NM, Wahed M, Koodun Y, Cantor EJ, Croft NM, Langmead FL et al.
(
2012
)
.
The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent
.
Aliment Pharmacol Ther
vol.
35
,
(
8
)
929
-
940
.
Goodhand JR, Kamperidis N, Rao A, Laskaratos F, McDermott A, Wahed M, Naik S, Croft NM et al.
(
2012
)
.
Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease
.
Inflamm Bowel Dis
vol.
18
,
(
3
)
513
-
519
.
Houston Y, Lindsay JO, Jenkins H, McCartney S, Ahmad T, Arnott I, Croft N, Russell R et al.
(
2012
)
.
Perspectives of transition care in inflammatory bowel disease: a survey
.
Gastrointestinal Nursing
vol.
10
,
(
1
)
30
-
35
.
Al Jawad FA, Cunningham SJ, Croft N, Johal A
(
2012
)
.
A qualitative study of the early effects of fixed orthodontic treatment on dietary intake and behaviour in adolescent patients
.
EUROPEAN JOURNAL OF ORTHODONTICS
vol.
34
,
(
4
)
432
-
436
.
Rao A, Kamperidis N, Koodun Y, Naik S, Croft NM, Sanderson IR
(
2012
)
.
RESPONSE TO ENTERAL NUTRITION PREDICTS INCREASED LENGTH OF REMISSION IN CHILDREN WITH CROHN'S DISEASE
.
GUT
.
vol.
61
,
A239
-
A239
.
Sebastian S, Jenkins H, McCartney S, Ahmad T, Arnott I, Croft N, Russell R, Lindsay JO
(
2012
)
.
The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and paediatric gastroenterologists
.
JOURNAL OF CROHNS & COLITIS
vol.
6
,
(
8
)
830
-
844
.
Goodhand J, Hedin CR, Croft NM, Lindsay JO
(
2011
)
.
Adolescents with IBD: the importance of structured transition care
.
J Crohns Colitis
vol.
5
,
(
6
)
509
-
519
.
Goodhand JR, Tshuma N, Rao A, Kotta S, Wahed M, Croft NM, Sanderson IR, Epstein J et al.
(
2011
)
.
Do children with IBD really respond better than adults to thiopurines?
.
J Pediatr Gastroenterol Nutr
vol.
52
,
(
6
)
702
-
707
.
Sebastian S, Jenkins H, Arnott I, Croft N, Ahmad T, McCartney S, Russell RK, Lindsay JO
(
2011
)
.
Barriers to transition care in inflammatory bowel disease: a survey of adult and paediatric gastroenterologists in the UK
.
Gut
.
vol.
60
,
Vossenkämper A, Marchès O, Fairclough PD, Warnes G, Stagg AJ, Lindsay JO, Evans PC, Luong LA et al.
(
2010
)
.
Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE
.
J Immunol
vol.
185
,
(
7
)
4118
-
4127
.
Goodhand J, Dawson R, Hefferon M, Tshuma N, Swanson G, Wahed M, Croft NM, Lindsay JO
(
2010
)
.
Inflammatory bowel disease in young people: the case for transitional clinics
.
Inflamm Bowel Dis
vol.
16
,
(
6
)
947
-
952
.
Rao A, Tshuma NB, Goodhand JR, Wahed M, Croft NM, Epstein J, Sanderson IR
(
2010
)
.
RESPONSE TO AZATHIOPRINE IN ADULTS AND CHILDREN WITH INFLAMMATORY BOWEL DISEASE IS COMPARABLE WHEN PHENOTYPE IS CONTROLLED
.
J PEDIATR GASTR NUTR
.
vol.
50
,
E112
-
E112
.
Wilson DC, Thomas AG, Croft NM, Newby E, Akobeng AK, Sawczenko A, Fell JME, Murphy MS et al.
(
2010
)
.
Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease
.
J Pediatr Gastroenterol Nutr
vol.
50 Suppl 1
,
S14
-
S34
.
Croft NM, Ferguson A
(
2009
)
.
High Intraluminal Fluid Flow Increases Intestinal IgA Output
.
Scandinavian Journal of Gastroenterology
vol.
35
,
(
7
)
726
-
731
.
Goodhand J, Tang JW, Naik S, Croft N, Lindsay JO
(
2009
)
.
W1115 Infliximab Use in Adolescents with Inflammatory Bowel Disease
.
Gastroenterology
vol.
136
,
(
5
)
a
-
657
.
Goodhand J, Tang J, Naik S, Croft NM, Lindsay JO
(
2009
)
.
INFLIXIMAB USE IN ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE
.
GUT
.
vol.
58
,
A63
-
A64
.
Goodhand J, Swanson G, Hefferon M, Dawson R, Croft NM, Lindsay J
(
2009
)
.
P004 - Specialist transitional clinics for adolescents with IBD limit exposure to diagnostic radiation
.
Journal of Crohn's and Colitis
vol.
3
,
(
1
)
s12
-
s12
.
Goodhand J, Tang J, Naik S, Croft NM, Lindsay J
(
2009
)
.
P207 - Infliximab use in adolescents with IBD
.
Journal of Crohn's and Colitis
vol.
3
,
(
1
)
s92
-
s92
.
Goodhand J, Tang JW, Naik S, Croft N, Lindsey JO
(
2009
)
.
Infliximab Use in Adolescents with Inflammatory Bowel Disease
.
GASTROENTEROLOGY
.
vol.
136
,
A657
-
A657
.
Ferguson A, Humphreys KA, Croft NM
(
2008
)
.
Technical Report: results of immunological tests on faecal extracts are likely to be extremely misleading
.
Clinical & Experimental Immunology
vol.
99
,
(
1
)
70
-
75
.
Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, Casson DH
(
2008
)
.
Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases
.
J Pediatr Gastroenterol Nutr
vol.
46
,
(
5
)
539
-
545
.
Dawson R, Hefferon M, Croft N, Lindsay JO
(
2008
)
.
T1201 IBD in Adolescents: A Case Control Study of Disease Extent and Therapeutic Strategy
.
Gastroenterology
vol.
134
,
(
4
)
a
-
506
.
Croft NM
(
2008
)
.
Gluten-free diets in celiac disease: does life mean life?
.
Gastroenterology
vol.
134
,
(
3
)
883
-
885
.
Naik S, Smith F, Ho J, Croft NM, Domizio P, Price E, Sanderson IR, Meadows NJ
(
2008
)
.
Staphylococcal enterotoxins G and I, a cause of severe but reversible neonatal enteropathy
.
Clin Gastroenterol Hepatol
vol.
6
,
(
2
)
251
-
254
.
Dawson R, Hefferon M, Croft N, Lindsay JO
(
2008
)
.
IBD in adolescents: A case control study of disease extent and therapeutic strategy
.
GASTROENTEROLOGY
vol.
134
,
(
4
)
A506
-
A506
.
Seerat I, Croft NM, Hickey A, Longhurst H
(
2008
)
.
IGG antibodies to foods are of no relevance to IGE mediated food allergy
.
GUT
.
vol.
57
,
A87
-
A87
.
Croft NM
(
2008
)
.
Ulcerative and Indeterminate Colitis
.
Walker's pediatric gastrointestinal disease
,
Editors:
Kleinman, RE, Goulet, O, Sanderson, IR, Sherman, PM et al.
,
Edition.
5th Revised edition
,
B.C. Decker
(
Hamilton
),
Karuppaswamy S, Croft N
(
2007
)
.
A case of multiple food allergies
.
CLINICAL AND EXPERIMENTAL ALLERGY
.
vol.
37
,
1876
-
1876
.
Köglmeier J, Croft N
(
2007
)
.
How to Prevent Growth Failure in Children
.
Clinical Dilemmas in Inflammatory Bowel Disease
,
Wiley
Daley A, Randall R, Darsley M, Choudhry N, Thomas N, Sanderson IR, Croft NM, Kelly P
(
2007
)
.
Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation
.
Gut
vol.
56
,
(
11
)
1550
-
1556
.
Di Sabatino A, Pickard KM, Gordon JN, Salvati V, Mazzarella G, Beattie RM, Vossenkaemper A, Rovedatti L et al.
(
2007
)
.
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease
.
Gastroenterology
vol.
133
,
(
4
)
1175
-
1187
.
Croft N, MACDONALD T, Monteleone G, Troncone R, Corazza GR, Stagg AG, Leakey NAM, Vossenkaemper A et al.
(
2007
)
.
Evidence for the role of interferon-Ą production by dendritic cells in the Th1 response in celiac disease
.
Gastroenterology
vol.
133
,
1175
-
87
.
Croft NM
(
2007
)
.
Biologicals move into the esophagus
.
Gastroenterology
vol.
133
,
(
1
)
358
-
360
.
Kamal-Uddin S, Croft NM
(
2006
)
.
Rotavirus vaccines: The wheel has turned
.
Gastroenterology
vol.
131
,
(
4
)
1352
-
1354
.
Lyall EGH, Langdale‐Brown B, Eden OB, Mok JYQ, Croft NM
(
2006
)
.
Ewing's sarcoma in a child with human immunodeficiency virus (type 1) infection
.
Pediatric Blood & Cancer
vol.
21
,
(
2
)
127
-
131
.
Afzal N, Lang HJ, Mills S, Green M, Naik S, Meadows N, Sanderson I, Croft N
(
2006
)
.
INFLAMMATORY BOWEL DISEASE PHENOTYPE IN BRITISH CHILDREN OF SOUTH ASIAN ORIGIN
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
42
,
(
5
)
e26
-
e26
.
Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB
(
2006
)
.
Inflammatory bowel disease
.
Arch Dis Child
vol.
91
,
(
5
)
426
-
432
.
Croft NM
(
2006
)
.
Phospholipid in UC: novel, safe and works--is it too good to be true?
.
Gastroenterology
vol.
130
,
(
3
)
1003
-
1004
.
Afzal NA, Hans-Joerg L, Mills S, Green M, Naik S, Meadows N, Sanderson I, Croft N
(
2006
)
.
Inflammatory bowel disease phenotype in British children of South Asian origin
.
GASTROENTEROLOGY
.
vol.
130
,
A215
-
A215
.
Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR
(
2005
)
.
Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children
.
Proc Natl Acad Sci U S A
vol.
102
,
(
37
)
13260
-
13265
.
Croft NM, Hodges M
(
2005
)
.
IgM: mucosal response in acute diarrhoeal disease of infants
.
Scand J Gastroenterol
vol.
40
,
(
8
)
965
-
971
.
Sanderson IR, Croft NM
(
2005
)
.
The anti-inflammatory effects of enteral nutrition
.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
.
vol.
29
,
S134
-
S140
.
Ho J, Croft N, Akanle A
(
2005
)
.
Bone mineral density at diagnosis in paediatric inflammatory bowel disease
.
BONE
.
vol.
36
,
S86
-
S86
.
Dogra H, Kruidenier L, Croft NM, Sanderson IR, Wilson JW
(
2005
)
.
Butyrate regulates the expression of the intestinal epithelial stem cell marker, Musashi-1
.
GASTROENTEROLOGY
.
vol.
128
,
A279
-
A279
.
Croft NM
(
2005
)
.
IgG food antibodies and irritating the bowel
.
Gastroenterology
vol.
128
,
(
4
)
1135
-
1136
.
Dogra H, Kruidenier L, Sanderson IR, Croft NM, Wilson JW
(
2005
)
.
Luminal regulation of intestinal epithelial stem cell fate
.
GUT
.
vol.
54
,
A78
-
A78
.
Sawczenko A, Idestrom M, Ballinger AB, Croft NM, Sanderson IR
(
2005
)
.
The -174 G/c interleukin-6 polymorphism determines growth failure in paediatric onset Crohn's disease
.
GASTROENTEROLOGY
.
vol.
128
,
A39
-
A39
.
Sawczenko A, Idestrom M, Ballinger AB, Croft NM, Sanderson IR
(
2005
)
.
The-174 G/C interleukin-6 polymorphism determines growth failure in paediatric onset Crohn's disease
.
GUT
.
vol.
54
,
A97
-
A98
.
Croft NM
(
2004
)
.
The spice of life for cystic fibrosis
.
Gastroenterology
vol.
127
,
(
5
)
1639
-
1640
.
Afzal NA, Mills S, Naik S, Sanderson I, Meadows N, Croft N
(
2004
)
.
P0652 INFLAMMATORY BOWEL DISEASE IN ASIAN CHILDREN RESIDENT IN UK
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
39
,
(
Supplement 1
)
Sawczenko A, Croft N, Sanderson I
(
2004
)
.
P0678 FINAL ADULT HEIGHT OF CHILDHOOD ONSET CROHN’S DISEASE: MEAN HEIGHT DEFICIT IS 3–4CM, BUT 25% DO NOT REACH THEIR GENETICALLY DETERMINED HEIGHT RANGE
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
39
,
(
Supplement 1
)
s314
-
s315
.
Rawat DJ, Yazaki ET, Meadows NM, Croft NM, Evans DF
(
2004
)
.
P1004 CAN ELECTROGASTROGRAPHY REPLACE GASTRIC EMPTYING FOR CHILDREN WITH GASTRIC DYSFUNCTION?
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
39
,
(
Supplement 1
)
Arthur SK, Nadeem A, Rawat D, Smith F, Wiles K, Croft N, Evans DF, Meadows N
(
2004
)
.
An appraisal of the impact of manometry on the management of children with feeding difficulties
.
GUT
.
vol.
53
,
A62
-
A62
.
Yazaki E, Hirata M, Rawat D, Croft N, Meadows N, Evans DF
(
2004
)
.
Can electrogastrography replace gastric emptying for children with gastric dysfunction?
.
GUT
.
vol.
53
,
A113
-
A113
.
Croft NM, Paraszczuk J, Ali E, Wilson JW, Jones SA, Naik S, Sanderson IR
(
2004
)
.
Is there a relationship between NOD2 polymorphism and response to polymeric enteral feed in children with Crohn's disease?
.
GUT
.
vol.
53
,
A32
-
A32
.
Daley AC, Croft N, Randall R, Kelly P
(
2004
)
.
Lack of a systemic immune response to oral vaccination does not indicate lack of mucosal immunity
.
GUT
.
vol.
53
,
A72
-
A72
.
Bannerjee K, Camacho-Hübner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR, Croft NM
(
2004
)
.
Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease
.
J Pediatr Gastroenterol Nutr
vol.
38
,
(
3
)
270
-
275
.
Bannerjee K, Camacho‐Hübner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR, Croft NM
(
2004
)
.
Anti‐Inflammatory and Growth‐Stimulating Effects Precede Nutritional Restitution During Enteral Feeding in Crohn Disease
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
38
,
(
3
)
270
-
275
.
Escher JC, European Collaborative Research Group on Budesonide in Paediatric IBD
(
2004
)
.
Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial
.
Eur J Gastroenterol Hepatol
vol.
16
,
(
1
)
47
-
54
.
Akanle OA, Ho J, Muhiddin K, Admans L, Croft NM, Spyrou NM
(
2004
)
.
Elemental composition of hair and bone density measurements at diagnosis in paediatric inflammatory bowel disease
.
J RADIOANAL NUCL CH
vol.
259
,
(
2
)
355
-
360
.
Fuchs G, Ahmed T, Araya M, Baker S, Croft N, Weaver L
(
2004
)
.
Malnutrition: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition
.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
.
vol.
39
,
S670
-
S677
.
Croft NM, Ho J, Akanle OA, Savage MO, Sanderson IR
(
2003
)
.
Decreased bone mineral density at diagnosis in paediatric inflammatory bowel disease
.
GUT
.
vol.
52
,
A21
-
A21
.
Naik S, Smith F, Ho J, Croft NM, Domizio P, Price E, Sanderson IR, Meadows NJ
(
2003
)
.
Staphylococcal enterotoxin G and I: A novel cause of severe neonatal enteropathy?
.
GUT
.
vol.
52
,
A101
-
A101
.
Naik S, Smith F, Ho J, Croft N, Domizio P, Sanderson I, Meadows N, Price E
(
2003
)
.
Staphylococcal enterotoxins G and I: A cause of severe neonatal enteropathy?
.
Gastroenterology
.
vol.
124
,
Sawczenko A, Ballinger AB, Croft NM, Sanderson IR, Savage MO
(
2003
)
.
Adult height in patients with early onset of Crohn's disease
.
Gut
vol.
52
,
(
3
)
454
-
455
.
CROFT NM, Pender SL, Salvati M, Monteleone G, Holloway J, Fairclough PD, MacDonald TT
(
2003
)
.
Activated STAT4 and a functional role for IL-12 in human Peyer's patches
.
J. Immunol.
vol.
170
,
(
1
)
300
-
307
.
CROFT NM
(
2003
)
.
Management of Crohn's disease in children
.
Management of Crohn's disease; Greig ER, Rampton DS, eds.
,
Martin Dunitz
(
London and New York
),
Ali E, Crouchman P, Meadows N, Sanderson IR, Croft NM
(
2002
)
.
Outcome of enteral feeding for newly diagnosed Crohn's disease
.
GUT
.
vol.
50
,
A71
-
A72
.
Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT
(
2001
)
.
Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease
.
J Clin Invest
vol.
108
,
(
4
)
601
-
609
.
Thapar N, Croft N, Meadows N, Evans D
(
2001
)
.
ACHALASIA IN CHILDREN: INCREASING INCIDENCE? EXPERIENCE OF BOTULINUM TOXIN THERAPY
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
32
,
Thapar N, Croft N, Meadows N, Evans D
(
2001
)
.
Achalasia in children: An increasing problem? Endoscopic use of botulinum toxin and experience from a single UK centre
.
GASTROINTEST ENDOSC
.
vol.
53
,
AB204
-
AB204
.
Kelly EJ, Naik S, Sanderson IR, Croft NM
(
2001
)
.
Elemental diet modulates the inflammatory response of enterocytes
.
GASTROENTEROLOGY
.
vol.
120
,
A674
-
A675
.
Croft NM
(
2001
)
.
Intestinal inflammation in cystic fibrosis
.
ARCH DIS CHILD
vol.
84
,
(
4
)
374
-
375
.
MacKay WG, Shepherd AJ, Doherty CP, Hossack M, Williams CL, Weaver LT
(
2001
)
.
340. FAMILY SIZE, SIBLINGS, SOCIOECONOMIC STATUS AND CHILDHOOD RISK OF HELICOBACTER PYLORI
.
Gut
vol.
48
,
(
suppl 1
)
Thapar N, Croft NM, Meadows N, Evans D
(
2001
)
.
Achalasia in children: An increasing and more severe problem? A single centre experience
.
GUT
.
vol.
48
,
A91
-
A91
.
Croft NM, Kelly EJ, Bannerjee K, Dryhurst K, Sanderson I
(
2001
)
.
Diets can modulate the inflammatory response in vivo and in vitro
.
GUT
.
vol.
48
,
A2
-
A2
.
Ballinger AB, Camacho-Hübner C, Croft NM
(
2001
)
.
Growth failure and intestinal inflammation
.
QJM
vol.
94
,
(
3
)
121
-
125
.
Kumberova A, CROFT NM, MacDonald TT, Steer HW, Monteleone G, McKenzie C
(
2001
)
.
Blocking Smad7 restores TGF-beta1 signalling in chronic inflammatory bowel disease
.
J. Clin. Invest.
vol.
108
,
(
4
)
601
-
609
.
CROFT NM
(
2001
)
.
Current treatment of IBD in children. [Review]
.
Hospital Prescriber Europe
vol.
2
,
29
-
31
.
Croft NM, Howatson AG, Ling SC, Nairn L, Evans TJ, Weaver LT
(
2000
)
.
Microvillous Inclusion Disease: An Evolving Condition
.
Journal of Pediatric Gastroenterology and Nutrition
vol.
31
,
(
2
)
185
-
189
.
Smyth RL, Croft NM, O'Hea U, Marshall TG, Ferguson A
(
2000
)
.
Intestinal inflammation in cystic fibrosis
.
Archives of Disease in Childhood
vol.
82
,
(
5
)
Bannerjee K, Croft NM, Babinska K, Camachno-Hubner C, Savage MO, Sanderson IR
(
2000
)
.
The influence of enteral feeding on growth factors, inflammation and nutrition in children with Crohn's disease
.
Gastroenterology
.
vol.
118
,
Croft NM, Hodges M, Ferguson A, Kabba LH
(
1998
)
.
IgM: THE PRIMARY IMMUNE RESPONSE IN ACUTE DIARRHOEA
.
Pediatric Research
vol.
44
,
(
3
)
426
-
426
.
Croft NM, Marshall TG, Ferguson A
(
1996
)
.
Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis
.
Postgraduate Medical Journal
vol.
72 Suppl 2
,
s32
-
s36
.
Doull I, Langton-Hewer S, Croft N, Marshall T, Ferguson A
(
1996
)
.
Gut inflammation in children with cystic fibrosis on high-dose enzyme supplementation
.
The Lancet
vol.
347
,
(
8997
)
Croft N, Heaf D
(
1996
)
.
Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis - Discussion
.
POSTGRADUATE MEDICAL JOURNAL
vol.
72
,
S36
-
S36
.
Marshall TG, Croft N, Ferguson A
(
1995
)
.
Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements
.
The Lancet
vol.
346
,
(
8985
)
1265
-
1267
.
Croft NM, Jacob AJ, Godman MJ, Boon NA, Mok JYQ
(
1993
)
.
Cardiac dysfunction in paediatric HIV infection
.
Journal of Infection
vol.
26
,
(
2
)
191
-
194
.
Croft N, Yap PL, Mok JYQ, Hague RA, Burns SM
(
1992
)
.
Zidovudine Therapy in Combination with Intravenous Immunoglobulin in HIV Infected Children
.
Scottish Medical Journal
vol.
37
,
(
5
)
138
-
141
.